Log in to search using one of your social media accounts:

 

RxSight wins FDA nod for light-adjustable IOL
The FDA has cleared RxSight‘s implantable light adjustable intraocular lens and light delivery device. The company’s RxSight IOL is designed from a UV light reactive material meant to be treated by a specific Light Delivery Device, intended for use 17 to 21 days post-procedure. The lens is designed to be treated by 3-4 light treatments over 1 to 2 weeks in 40 to 150 second treatment periods, during which the patient must wear UV-protective glasses. “Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery. This syste...
Source: Mass Device - November 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance rxsight Source Type: news

Minimally Invasive Brow Lifting Techniques Minimally Invasive Brow Lifting Techniques
This article reviews the efficacy of several minimally invasive browpexy techniques to address brow ptosis. How do they measure up?Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 22, 2017 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

Restasis buyers level antitrust lawsuit against Allergan
A proposed class of Restasis buyers filed an antitrust suit last week in a Texas federal court against Allergan (NYSE:AGN), according to reports from Law360. The suit accuses Allergan of blocking generics to its dry-eye drug using tactics like sham infringement suits and a controversial deal with a Native American tribe. Get the full story at our sister site, Drug Delivery Business News. The post Restasis buyers level antitrust lawsuit against Allergan appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Optical/Ophthalmic Patent Infringement Pharmaceuticals Wall Street Beat Allergan Source Type: news

FDA clears remote adjustments for Cochlear ’ s Nucleus implants
The FDA last week approved remote programming adjustments for Cochlear Ltd.‘s (ASX:COH) Nucleus cochlear implant, removing the need for a select group of users  to make repeat visits for in-person programming sessions. The newly-cleared remote programming feature is indicated for patients with 6 months of experience with their cochlear implant sound processors and who are comfortable with the programming process, according to an FDA release. Normally, such implants would require regular programming visits with an audiologist in which electronic settings that control how the implant stimulates nerves in the ear a...
Source: Mass Device - November 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance Cochlear Ltd. Source Type: news

Cambridge Consultants prototypes miniaturized robot for cataract surgery
Cambridge Consultants showed off its prototype of a miniaturized robot designed for cataract surgery last week at its annual Innovation Day event. The system, Axsis, is one of the smallest known robots for surgical use, according to the firm, featuring instruments of just 1.8mm in diameter. Get the full story at our sister site, The Robot Report. The post Cambridge Consultants prototypes miniaturized robot for cataract surgery appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Optical/Ophthalmic Robotics Surgical Cambridge Consultants Source Type: news

Simple Checklist Can Identify Useful Clinical Practice Guidelines
Eight - item tool developed for clinicians to identify trustworthy, useful, and relevant guidelines (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 18, 2017 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Autorefraction Assessment, Eyeglasses by Mail May Help the Underserved Autorefraction Assessment, Eyeglasses by Mail May Help the Underserved
A screening program in Baltimore that used autorefraction to assess patients ’ eyesight, and then provided free eyeglasses to them, yielded a high level of satisfaction, according to a new report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Eye to the Sky: Ophthalmologists Aided Hurricane Response Eye to the Sky: Ophthalmologists Aided Hurricane Response
Eye care is one of the most common acute medical needs after natural disasters, and having a plan in place speeds aid.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Excitons seen in bilayer graphene
New result bodes well for next-generation optoelectronics instruments, such as tunable infrared detectors, light-emitting diodes and lasers. (Source: Nanotechweb.org News)
Source: Nanotechweb.org News - November 17, 2017 Category: Nanotechnology Authors: Belle Dum é Source Type: news

Erlotinib Overdose Tied to Conjunctivitis
Findings in case study of man being treated for non - small - cell lung cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 17, 2017 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Emergency Medicine, Oncology, Ophthalmology, Pharmacy, Journal, Source Type: news

Staar Surgical plans pivotal of Visian EVO ICL presbyopia optic for Q1 2018
Staar Surgical (NSDQ:STAA) this week reported results from the feasibility clinical study of its Evo+ Visian ICL with aspheric optics designed to reduce presbyopia, and that based on the results it plans to launch a pivotal clinical study of the device during the 1st quarter next year. The Monrovia, Calif.-based company’s EVO+ Visian ICL is designed to be surgically implanted and operate with the patient’s eye to correct vision. The lens is designed to be positioned inside the eye between the iris and natural lens where it stays indefinitely. Staar Surgical said that it presented results from 24 patients i...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic STAAR Surgical Co Source Type: news

Implandata Ophthalmic touts 1st-in-human use of next-gen Eyemate IOP sensor
Implandata Ophthalmic Products today touted the first-in-human use of its next-gen Eyemate micro-sensor implant designed to monitor intraocular pressure. The Eyemate microsensor is designed for the continuous monitoring of intraocular pressure and can be checked remotely, removing the need for a patient to visit a doctor’s office for measurements, the Hannover, Germany-based company said. “This opens up the path to proceed forward towards design finalization, expanded clinical validation and regulatory approval. Eventually this will further increase the use of the Eyemate system,” CEO Max Ostermeier ...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Optical/Ophthalmic Implandata Ophthalmic Products Source Type: news

iVeena finishes pilot trial of sustained-release implant
iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery. Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule. Get the full story at our sister site, Drug Delivery Business News. The post iVeena finishes pilot trial of sustained-release implant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Optical/Ophthalmic Pain Management Pharmaceuticals Surgical iveenadeliverysystems Source Type: news

Vyzulta (Latanoprostene Bunod Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 17, 2017 Category: Drugs & Pharmacology Source Type: news

Baby Boomers at Lower Risk for Macular Degeneration Than Their Predecessors
Baby Boomers appear less likely than their predecessors to develop macular degeneration, according to a study in JAMA Ophthalmology. Researchers examined nearly 5000 adults in... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 17, 2017 Category: Primary Care Source Type: news

Stem Cell Therapy Shows Promise for Retinal Degeneration Stem Cell Therapy Shows Promise for Retinal Degeneration
Retinal pigment epithelial cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Choose DMEK Over DSEK After Glaucoma Surgery Choose DMEK Over DSEK After Glaucoma Surgery
Descemet membrane endothelial keratoplasty provides better outcomes than Descemet-stripping in patients requiring cornea transplant who have already had glaucoma surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

$1 million price tag in spotlight as gene therapy becomes reality
LONDON (Reuters) - Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare form of blindness and creating a cost dilemma for healthcare providers. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Optogenetic Therapies Move Closer to Clinical Use
With a clinical trial underway to restore vision optogenetically, researchers also see promise in using the technique to treat deafness, pain, and other conditions. (Source: The Scientist)
Source: The Scientist - November 16, 2017 Category: Science Tags: News & Opinion,News Analysis,The Scientist Source Type: news

Indian man has metallic wire hanging out of his eye
Ophthalmologists at the All India Institute of Medical Sciences in New Delhi revealed the strange incident in the British Medical Journal Case Reports. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

Staying Active May Lower Odds for Glaucoma
Title: Staying Active May Lower Odds for GlaucomaCategory: Health NewsCreated: 11/15/2017 12:00:00 AMLast Editorial Review: 11/16/2017 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - November 16, 2017 Category: Opthalmology Source Type: news

Research reveals biological mechanism of a leading cause of childhood blindness
(Virginia Tech) Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Health Care Experts in Favor of Patient Contribution to Notes
With some cautions, experts are supportive of the OurNotes medical notes intervention (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 16, 2017 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Allergy, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Psychiatry, Pulmonology, Rheumatology, Urology, Anesthesiology Source Type: news

Experts warn: Ethical guidelines and regulations are needed for AI technology used to restore or enhance human capabilities
(Natural News) A group of 28 researchers, scientists and other experts in the neurotechnology field is calling for ethical rules when it comes to the brain-computer interface. Artificial intelligence technology brings with it the possibility of profoundly restoring the quality of life for many individuals suffering from brain injuries, blindness, paralysis, epilepsy, and other serious conditions.... (Source: NaturalNews.com)
Source: NaturalNews.com - November 15, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Exercise may protect you from glaucoma
The results of a new study show that people who engage in moderate- to vigorous-intensity exercise have a 73 percent lower risk of developing glaucoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 15, 2017 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Maxidex Ointment (Dexamethasone Sodium Phosphate Ophthalmic) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Vyzulta (Latanoprostene Bunod Ophthalmic Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Maxidex Suspension (Dexamethasone Ophthalmic Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

After cooking, biofortified corn and eggs retain nutrient needed to prevent blindness
(American Chemical Society) Fortified and biofortified foods are at the forefront of efforts to combat vitamin A deficiency worldwide. But little is known about what influence processing may have on the retention of vitamin A precursors in these foods. Now in a study appearing in ACS Omega, scientists report that a high percentage of these healthful substances -- in some cases, almost all -- can survive cooking, depending on the preparation method.   (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 15, 2017 Category: Biology Source Type: news

Diabetic Macular Edema Vastly Undertreated Diabetic Macular Edema Vastly Undertreated
Most patients with newly diagnosed diabetic macular edema are inadequately treated, according to findings from the American Academy of Ophthalmology's IRIS Registry.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Beware of Illegal Breast and Butt Implants
FDA is cracking down on illegal products intended to boost the size of a person's breasts, butt, or other body parts. “We have significant concerns with unsafe injectable silicone that’s being marketed for body contouring by unlicensed providers. We’ve seen serious adverse events result from products, which are sometimes industrial-grade silicone, being used for these unapproved medical purposes,” said FDA Commissioner Scott Gottlieb, MD. “The FDA has stepped in to take enforcement actions against unscrupulous actors who promote and provide these services, but we also want to make the public a...
Source: MDDI - November 14, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Major research funding envisions eyesight restoration
A team of Yale researchers is working to develop advanced systems to produce digital sensory data that the brain decodes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 14, 2017 Category: Universities & Medical Training Source Type: news

HRT may protect against glaucoma
New research presented at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology, reports that oestrogen therapy is associated with a lower risk of eye disease.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 14, 2017 Category: Endocrinology Source Type: news

CMS Will See You Now CMS Will See You Now
Physicians'voices are going to be heard in Washington, DC, and regulatory burdens that are dragging down physicians'practices will be eased, Seema Verma said at the American Academy of Ophthalmology meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

SUNY downstate receives $2 million for research into vision-threatening diseases
(SUNY Downstate Medical Center) Brahim Chaqour, PhD, professor of cell biology and ophthalmology at SUNY Downstate Medical Center, has received two awards to support research into treatment of currently incurable vision-threatening diseases. The new awards, totaling $2,008,973, are from the National Eye Institute of the National Institutes of Health (NIH). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Drivers 'should have compulsory eye tests'
One in three optometrists say they know of patients who drive with vision below the legal standard. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 14, 2017 Category: Consumer Health News Source Type: news

Study: Mobile app could help monitor AMD and diabetic retinopathy
A new study found that a mobile-based app could be an effective way of monitoring age-related mucular degeneration (AMD) and diabetic retinopathy. A study recently presented at the American Academy of Ophthalmology or AAO, reported that patients who used DigiSight's Paxos Checkup app, got comparable results to those who had traditional clinical checkups.   (Source: mobihealthnews)
Source: mobihealthnews - November 13, 2017 Category: Information Technology Source Type: news

Novel Intraocular Lens May Prevent Negative Dysphotopsia Novel Intraocular Lens May Prevent Negative Dysphotopsia
A novel intraocular lens design appeared to prevent negative dysphotopsia after cataract surgery, according to prospective studies involving 100 patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

UAB expands Vision Therapy Clinic
The University of Alabama at Birmingham School of Optometry has expanded it Vision Therapy Clinic.   This expansion will enable more than twice as many patients with conditions affecting eye teaming, visual tracking and focusing to be treated.  “When I started at UAB, it was my goal to bring therapy services to our patients and to give the School of Optometry students an education that woul d allow them to provide vision therapy services to their patients after graduation,” said Kristine Hopkins,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2017 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Complement Inhibitor Fails in Trials for Geographic Atrophy Complement Inhibitor Fails in Trials for Geographic Atrophy
Complement inhibition as a means of halting the progression of geographic atrophy took a hit this week, with negative findings announced for two pivotal phase 3 clinical trials of lampalizumab.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Soluble Interleukin 2 Receptor IDs Sarcoidosis in Uveitis
sIL - 2R has slightly better diagnostic value than ACE for sarcoidosis in patients with uveitis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 13, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Emergency Medicine, Ophthalmology, Pathology, Pulmonology, Rheumatology, Journal, Source Type: news

Wouldn't it be great if eyedrops didn't spill out of your eyes?
(American Academy of Ophthalmology) A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

At-home vision monitoring app may improve patient care
(American Academy of Ophthalmology) Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

Next-generation optogenetic molecules control single neurons
(Massachusetts Institute of Technology) Researchers at MIT and Paris Descartes University have developed a new optogenetic technique that allows them stimulate individual neurons with precise control over both the location and timing of the activation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

Research to Prevent Blindness and American Academy of Ophthalmology announce new grant opportunities to support vision research
(American Academy of Ophthalmology) Research to Prevent Blindness and the American Academy of Ophthalmology today announced that they have created a new category of grant to support researchers who want to use the Academy's IRIS ® Registry database to conduct population-based studies in ophthalmology and blindness prevention. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 11, 2017 Category: International Medicine & Public Health Source Type: news

Genetic treatment for blindness may soon be reality
(American Academy of Ophthalmology) Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

Mass. panel reviews cataract surgery adverse events, makes recommendations for prevention
(Massachusetts General Hospital) A team of specialists in anesthesiology, ophthalmology and patient safety convened in response to a series of injuries to patients receiving cataract surgery has reported its findings regarding factors contributing to those and other adverse events and strategies for preventing patient harm in such procedures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

Harnessing the unique properties of soft matter
Liquid-crystalline fluids are used in many modern optoelectronic devices, from medical tools to smart phone and computer screens - probably including the display you are reading this on. A related soft matter technology currently being explored by EU-funded researchers could have a broad range of novel industrial and commercial applications. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 10, 2017 Category: Research Source Type: news

Two thirds of eye units restricting access to cataract surgery
Commissioners are ignoring NICE guidance, says Royal College of Ophthalmologists Related items fromOnMedica Eye problems Hopes for early warning glaucoma detector STPs can help CCGs deliver eye care at scale Ongoing concerns that cataract surgery being cut to save cash (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 10, 2017 Category: UK Health Source Type: news

Johnson and Johnson Vision Announces TearScience LipiScan(R) and LipiFlow(R) Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction
Meibomian Gland Dysfunction (MGD) is a primary cause of dry eye disease, which impacts more than 340 million people globally LipiScan® and LipiFlow® technologies offer rapid, effective solutions for optometry and ophthalmology practices in North... Devices, Ophthalmology, Product Launch Johnson & Johnson, TearScience, LipiScan, LipiFlow, Meibomian Gland, dry eye (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2017 Category: Pharmaceuticals Source Type: news